7,648 bytes removed ,  17:26, 8 September 2015
no edit summary
Line 1: Line 1: −
==Description==
+
{{OpenPagesTop}}
 
+
==Introduction==
 +
[[Image:Chronic Allergic Otitis.jpg|thumb|right|200px|Chronic allergic otitis in the dog. Source: Wikimedia Commons; Author: Caroldermoid (2006)]]
 
Atopic dermatitis is a heritable disorder in which animals are hypersenstive to common environmental allergens. It is one of the most common skin diseases of dogs worldwide.
 
Atopic dermatitis is a heritable disorder in which animals are hypersenstive to common environmental allergens. It is one of the most common skin diseases of dogs worldwide.
   −
The most common allergens involved in atopic dermatitis are those of house dust mites (''Dermatophagoides farinae'') and grain mites. Human and animal danders, house dust, grass and tree pollen and moulds also frequently incite reactions. Susceptible animals produce allergen-specific IgE to these normally-innocuous allergens, which then binds to receptors on cutaneous mast cells. Atopic animals may have defects in the epidermis, leading to impaired barrier function, and it is thought that further allergen exposure occures via percutaneous absorption. This further exposure gives mast cell degranluation, releasing istamine, cytokines, chemokines, leukotrienes, prostaglandins and other chemical mediators. This is a type 1 (immediate) hypersensitivity reaction<sup>1</sup>, and leads to vasodilation, inflammatory cell infiltration and pruritus. It appears that the cytokines involved are abnormally biased towards a Th2 response. IL-4 in particular is produced; this cytokine is responsible for B-cell production of IgE. Bacterial superantigens and autoantigens released due to keratinocyte damage play a role in perpetuating inflammation.
+
The most common allergens involved in atopic dermatitis are those of house dust mites (''Dermatophagoides farinae'') and grain mites. Human and animal danders, house dust, grass and tree pollen and moulds also frequently incite reactions. Susceptible animals produce allergen-specific IgE to these normally-innocuous allergens, which then binds to receptors on cutaneous mast cells. Atopic animals may have defects in the epidermis, leading to impaired barrier function, and it is thought that further allergen exposure occurs via percutaneous absorption. This further exposure gives mast cell degranluation, releasing histamine, cytokines, chemokines, leukotrienes, prostaglandins and other chemical mediators. [[Type I Hypersensitivity|This is a type 1 (immediate) hypersensitivity]] reaction<sup>1</sup>, and leads to vasodilation, inflammatory cell infiltration and pruritus. It appears that the cytokines involved are abnormally biased towards a Th2 response. IL-4 in particular is produced; this cytokine is responsible for B-cell production of IgE. Bacterial superantigens and autoantigens released due to keratinocyte damage play a role in perpetuating inflammation.
    
==Signalment==
 
==Signalment==
 
+
Atopic dermatitis is a disease of dogs, although it can occur sporadically in the cat<sup>1</sup>. The typical age of onset of atopic dermatitis is between 6 months and 3 years of age and signs are hardly ever seen in animals under 6 months of age. Signs may be so mild at first that they are not noted, but usually progress to become clinically apparent<sup>1</sup>. Atopy is heritable and so breed predispositions occur. Susceptible breeds include the : Beauceron, Boston Terrier, Boxer, Cairn Terrier, Cocker Spaniel, Dalmation, English Bulldog, English Setter, Fox Terrier, Sealyham Terrier, Setters, Shar-Pei, West Highland White Terrier, Wire Haired Fox Terrier, and Yorkshire Terrier<sup>2</sup>. Certain breeds such as the Cocker Spaniel, Dachshund, Doberman Pinscher, German Shepherd, German Short-Haired Pointer and Poodle appear to have a decreased risk of atopy. There is no sex predilection.
Atopic dermatitis is a disease of dogs, although it can occur sporadically in the cat<sup>1</sup>. The typical age of onset of atopic dermatitis is between 6 months and 3 years of age and signs are hardly ever seen in animals under 6 months of age. Signs may be so mild at first thtat they are not noted, but usually progress to become clinically apparent<sup>1</sup>. Atopy is heritable and so breed predispoitions occur. Susceptible breeds include the : Beaceron, Boston Terrier, Boxer, Cairn Terrier, Cocker Spaniel, Dalmation, English Bulldog, English Setter, Fox Terrier, Sealyham Terrier, Setters, Shar-Pei, West Highland White Terrier, Wire Hiared fox Terrier, and Yorkshire Terrier<sup>2</sup>. Certain breeds such as the Cocker Spaniel, Dachshund, Doberman Pinscher, German Shepherd, German Short-haired Pointer and Poodle appear to have a decreased risk of atopy. There is no sex predilection.
      
==Diagnosis==
 
==Diagnosis==
 
+
The diagnosis of atopic dermatitis is based on the signalment, a thorough history and appropriate physical examination findings. Other causes of pruritus must also be ruled out. The differential diagnoses are<sup>1</sup>:
The diagnosis of atopic dermatitis is based on the signalment, athorough history and appropriate physical examination findings. Other causes of pruritus must also be ruled out. The differential diagnoses are<sup>1</sup>:
   
*Food allergy: ruled out by a dietary exclusion trial.
 
*Food allergy: ruled out by a dietary exclusion trial.
*Flea allergy dermatitis: ruled out observing response to ectoparasiticides.
+
*[[Flea Allergic Dermatitis|Flea allergy dermatitis]]: ruled out observing response to ectoparasiticides.
*Contact dermatitis: ruled out by confining animal to one area covered in e.g. newspaper.
+
*[[Contact Dermatitis|Contact dermatitis]]: ruled out by confining animal to one area covered in e.g. newspaper.
*Scabies:ruled out observing response to ectoparasiticides.
+
*[[Sarcoptic Mange|Scabies]]:ruled out observing response to ectoparasiticides.
   −
Intradermal and serologic allergy testing are available but are not used to make a diagnosis of atopy. Their purpose is to identify the specific offending allergens in an animal in order than immunotherapy may be pursued. The results of allergy testing are only significant if the history and clinical signs are also suggestive of atopic dermatitis.  
+
Intradermal and serologic allergy testing are available but are not used to make a diagnosis of atopy. Their purpose is to identify the specific offending allergens in an animal in order that immunotherapy may be pursued. The results of allergy testing are only significant if the history and clinical signs are also suggestive of atopic dermatitis.  
    
===Clinical Signs===
 
===Clinical Signs===
 +
Signs are often, but not always, seasonal. Pruritus is the hallmark of atopic dermatitis and may be the only complaint. This gives rise to self-trauma, causing lesions. Lesions commonly include alopecia, erythema, scaling, crusting, excoriations and salivary staining. Macular-papular eruptions are occasionally seen<sup>2</sup>. With time, lichenification, and hyperpigmentation develops. Because the route of allergen contact is thought to be percutaneous absorption<sup>1, 2</sup>, it follows that hairless regions are most frequently affected: the face, ears, axillae, feet and inguinal regions are predilection sites. Secondary infections such as superficial staphylococcal pyoderma and [[Malassezia pachydermidis|''Malassezia'']] are common, and otitis externa often occurs concurrently<sup>2, 3, 4</sup>. A small number of cases exhibit only chronic or recurrent otitis externa. Another uncommon presentation is allergic rhinitis, manifesting as sneezing, nasal discharge or allergic conjunctivitis<sup>1, 2</sup>.
   −
Signs are often, but not always, seasonal. Pruritus is the hallmark of atopic dermatitis and may be the only complaint. This gives rise to self-trauma, causing lesions. Lesions commonly include alopecia, erythema, scaling, crusting, excoriations and salivary staining. Macular-papular eruptions are occasionally seen<sup>2</sup>. With time, lichenification, and hyperpigmentation develops. Because the route of allergen contact is thought to be percutaneous absorption<sup>1, 2</sup>, it follows that hairless regions are most frequently affected: the face, ears, axillae, feet and inguinal regions are predilection sites. Secondary infections such as superficial staphylococcal pyoderma and ''Malassezia'' are common, and otitis externa often occurs concurrently<sup>2, 3, 4</sup>. A small number of cases exhibit only chronic or recurrent otitis externa. Another uncommon presentation is allergic rhinitis, manifesting as sneezing, nasal discharge or allergic conjunctivitis<sup>1, 2</sup>.
+
Signs commonly seen in different species are:
 +
:Dogs - face rubbing and foot licking; secondary [[Pyoderma|pyoderma]] or [[Seborrhea|seborrhea]]
 +
:Cats - facial, ear or generalised pruritus, [[Feline Miliary Dermatitis|miliary dermatitis]], [[Feline Eosinophilic Granuloma|eosinophilic granuloma complex]], symmetric alopecia
 +
:Horses - pruritic hea, pinnae, ventrum, legs, tailhead or recurrent [[Urticaria|urticaria]]
    
===Laboratory Tests===
 
===Laboratory Tests===
 +
Routine haematology and biochemistry rarely show any abnormalities in dogs, but eosinophilia is often seen in cats<sup>1</sup>. The measurement of total serum IgE levels is not useful in the diagnosis of atopic dermatitis as IgE levels do not significantly differ between atopic and normal animals<sup>2</sup>. IgE levels are also influenced by the presence of parasites, vaccinations and breed, and so this test is not reliable.
   −
Routine haematology and biochemistry rarely show any abnormalities in dogs, but eosinophilia is often seen in cats<sup>1</sup>. The measurement of total serum IgE levels is not useful in the diagnosis of atopic dermatitis as IgE levels do not significantly differ betweem atopic and normal animals<sup>2</sup>. IgE levels are also influence by the presence of parasites, vaccinations and breed, and so this test is not reliable
+
Allergen-specific IgE tests are only useful when a diagnosis of atopic dermatitis has already been reached by consideration of history and clinical exam, and by ruling out other causes of pruritus. The test is used to identify allergens for immunotherapy by evaluating serum levels of IgE specific for a variety allergens. The exact technique varies between laboratories, but the principle is the same: serum is allowed to react with the allergen before excess serum and antibodies are rinsed away. An IgE-specific reagent linked to an indicator is added, and the amount that binds is proportional to the amount of allergen-specific IgE<sup>2</sup>. This can then be quantified. Several factors can adversely influence the test results. These include age, season, use of corticosteroids and laboratory inaccuracies.
 
  −
Allergen-specific IgE tests are only useful when a diagnosis of atopic dermatitis has already been reached by consideration of histoty and clinical exam, and by ruling out other causes of pruritus. The test is used to identify allergens for immunotherapy by evaluating serum levels of IgE specific for a variety allergens. The exact technique varies between laboratories, but the principle is the same: serum is allowed to react with the allergen before excess serum and antibodies are rinsed away. An IgE-specific reagent linked to an indicator is added, and the amount that binds is proportional to the amount of allergen-sprecific IgE<sup>2</sup>. This can then be quantified. Several factors can adversely influence the test results. These include age, season, use of corticosteroids and laboratory inaccuracies.
      
===Other Tests===
 
===Other Tests===
 +
Intradermal skin tests determine the ability of allergens injected intradermally to cause mast cell degranulation leading to a subsequent wheal and flare reaction. It is therefore a close approximation of the pathogenesis of atopic dermatitis, and is a useful tests for revealing specific allergens for use in immunotherapy. Aqueous allergens are used for testing and include such things as house dust mites, pollens, moulds, insects and epidermal antigens. These should be stored in the fridge to maintain potency, and allowed to reach room temperature before testing<sup>2</sup>. Test results can be affected or inhibited by numerous factors such as medications, sedatives and stress. Drugs shown to affect intradermal skin testing include antihistamines, tricyclic antidepressants and glucocorticoids. Withdrawal times of 2, 4 and 6 weeks have been suggested for topical, oral and long-acting injectable steroids respectively<sup>3</sup>, although this may be difficult in a very pruritic animal. Some animals require sedation for intradermal skin testing and xylazine and medetomidine have been shown not to affect results. Diazepam and acepromzine should not be used<sup>2</sup>.
   −
Intradermal skin tests determine the ability of allergens injected intradermally to cause mast cell degranulation leading to a subsequent wheal and flare reaction. It is therefore a close approximation of the pathogenesis of atopic dermatitis, and is a useful tests for revealing specific allergens for use in immunotherapy. Aqueous allergens are used for testing and include such things as house dust mites, pollens, moulds, insects and epidermal antigens. These should be stored in the fridge to maintain potency, and allowed to reach room temperature before testing<sup>2</sup>. Test results can be affected or inhibited by numerous factors such as medications, sedatives and stress. Drugs shown to affect intradermal skin testing include antihistamines, tricyclic antidepressants and glucocorticoids. Withdrawal times of 2, 4 and 8 weeks have been suggested for topical, oral and long-acting injectable steroids respectively, although this may be diffcult in a very pruritic animal. Some animals require sedation for intradermal skin testing and xylazine and medetomidine have been shown not to affect results. Diazepam and acepromzine should not be used<sup>2</sup>.
+
Fine needles are used to inject allergen intradermally. Histamine is used as a positive control, and isotonic saline as a negative. Approximately 0.05-1.0 ml solution is injected at each site, and after around 15 minues the test is read by scoring each allergen based on the size of the bleb.
 
  −
26-27 gauge needles are used to inject allergen intradermally. Histamine is used as a positive control, and isotonic saline as a negative. Approximately 0.05-1.0 ml solution is injected at each site, and after around 15 minues the test is read by scoring each allergen based on the size of the bleb.
      
===Biopsy===
 
===Biopsy===
   
Biopsies may help rule out other differential diagnoses, but do not show any pathognomic changes for atopic dermatitis<sup>1</sup>.
 
Biopsies may help rule out other differential diagnoses, but do not show any pathognomic changes for atopic dermatitis<sup>1</sup>.
    
===Pathology===
 
===Pathology===
 +
Gross findings reflect the lesions seen in life and lesions are generally due to self-trauma.
   −
Gross findings reflect the lesions seen in life.
+
Histological changes are non-specific but include acanthosis, a mixed mononuclear perivascular dermatitis, sebaceous gland metaplasia and secondary superficial pyoderma<sup>1</sup>.
   −
Histologic changes are non-specific but include acanthosis, a mixed mononuclear perivascular dermatitis, sebaceous gland metaplasia and secondary superficial pyoderma<sup>1</sup>.
+
Other microscopical findings include: hyperplastic superficial perivascular dermatitis, mast cells, eosinophils and nonmetachromatic mononuclear cells. Perivascular inflammation may be involved especially in horses.
    
==Treatment==
 
==Treatment==
   
Several factors exist that in normal dogs may by insufficient to cause pruritus. However, when these occur at the same time as allergen exposure in atopic dogs, there can be an additive effect that breaks the threshold for pruritus. These "flare factors" include ectoparasites, microbial infections, stress and environmental effects. When treating for atopic dermatitis it is therefore critical to keep these factors to a minimum. Atopic dogs should be regularly treated with an ectoparasiticide against fleas and mites, and secondary bacterial or ''Malassezia'' infections should be identified and treated promptly. Stress should be avoided and products that may be irritant, such as cleaning materials, should not be used in the environment. This requires a certain amount of vigilance on the part of the owners.
 
Several factors exist that in normal dogs may by insufficient to cause pruritus. However, when these occur at the same time as allergen exposure in atopic dogs, there can be an additive effect that breaks the threshold for pruritus. These "flare factors" include ectoparasites, microbial infections, stress and environmental effects. When treating for atopic dermatitis it is therefore critical to keep these factors to a minimum. Atopic dogs should be regularly treated with an ectoparasiticide against fleas and mites, and secondary bacterial or ''Malassezia'' infections should be identified and treated promptly. Stress should be avoided and products that may be irritant, such as cleaning materials, should not be used in the environment. This requires a certain amount of vigilance on the part of the owners.
   −
===Improving skin barrier function===
+
===Improving Cutaneous Barrier Function===
In normal animals, the skin has an important barrier function. The integrity of the epithelium may be impaired in atopic animals, facilitating further exposure to allergens. Finding ways to help improve the barrier function of the epidermis can contribute towards the effective management of atopy.
+
In normal animals, the skin has an important barrier function. The integrity of the epithelium may be impaired in atopic animals, facilitating further exposure to allergens. Finding ways to help improve the barrier function of the epidermis can contribute towards the effective management of atopy. Food trials are often used during the course of a work-up for atopic dermatitis to eliminate food allergy as a cause of pruritus. Many atopic animals non-specifically improve during food trials on prescription hypoallergenic diets, which may be attributable to several of their components. The inclusion of zinc and long-chain omega essential fatty acids is thought to reduce inflammation, and substances such as inositol, choline, histidine, pantothenate and nicotinamide may help improve epidermal lipid barrier<sup>3</sup>. The use of topical shampoos and emollients can also be beneficial. As well as physically removing allergens from the skin and coat, moisturising shampoos can hydrate the skin and improve the lipid barrier. Colloidal oatmeal may also have a direct antipruritic action<sup>3</sup>. Anti-microbial or anti-scaling shampoos, and ear cleaners can prove useful in certain cases depending on presentation. The effects of essential fatty acids in atopic dermatitis have been subjected to numerous clinical trials. EFA supplementation alters incorporation into cell membranes, which may reduce production of pro-inflammatory leukotrienes and prostaglandins<sup>3</sup>. The cutaneous lipid barrier may also be improved. However, there is some conflicting informtation, and high levels of supplementation may be neccessary to give beneficial effects.
   −
Food trials are often used during the course of a work-up for atopic dermatitis to eliminate food allergy as a cause of pruritus. Many atopic animals non-specifically improve during food trials on prescription hypoallergenic diets, which may be attributable to several of their components. The inclusion of zinc and long-chain omega essential fatty acids is thought to reduce inflammation, and substances such as inositol, choline, histidine, pantothenate and nicotinamide may help improve epidermal lipid barrier<sup>4</sup>.
+
===Allergen Specific Therapy===
 +
In animals with demonstrated sensitivities to specific allergens, allergen-specific therapy can form part of the treatment regimen for atopic dermatitis. It may be possible to limit exposure to certain allergens. For example, exposure to house dust mites can be limited by keeping animals out of the bedroom and using hypoallergenic mattresses and pillow covers. Filtered vacuum cleaners can be used, and animals should be kept out of rooms for two to three hours after vacuuming. Soft toys harbour many dust mites and so should be avoided, or frozen for 24 hours once a month to keep the burden low. The animal's bedding should be washed at a temperature of greater than 70&deg;C and the bed wiped out regularly with a damp cloth. Environmental flea control products are effective at killing dust mites in the home. If the animal is allergic to pollens, walking routes can be altered to avoid contact with the specific source, be it grasses, trees or weeds. Dogs can be washed after walking through vegetation to remove allergens, and lawns can be mown short.
   −
The use of topical shampoos and washes can also be beneficial. As well as physically removing allergens from the skin and coat, moisturising shampoos can hydrate the skin and improve the lipid barrier. Colloidal oatmeal may also have a direct antipruritic action<sup>4</sup>. Anti-microbial or anti-scaling shampoos, and ear cleaners can prove useful in certain cases depending on presentation.
+
Allergen specific immunotherapy (ASIT) can also be implemented. This involves the subcutaneous injection of gradually increasing quantities of allergen. The mechanism of action is not fully understood but it seems that administering large doses of allergen in an unusual route results in tolerance<sup>3</sup>. This may be because IgG level increase during the first few months of hyposensitization and binds circulating allergens, thereby blocking them from causing mast cell degranulation<sup>4</sup> The effects of ASIT are highly variable: around 25% of dogs can be controlled with immunotherapy alone, a further 50% show some improvement, and 25% are non-responsive. Effects can take some time to be appreciated, and so a 9 to 12 month trial of immunotherapy is recommended. Generally, injections are initially given 1-2 weeks apart, building up to the full dose. Animals are usually monitored for around 30mins after the first few treatments, because anaphylaxis is an uncommon side-effect. Once the full dose is reached, the interval between injections can be extended to roughly once monthly. Most animals require ongoing treatment at this interval to maintain the effects of ASIT, but a few animals can be gradually weaned off ASIT.
   −
====Essential fatty acids (EFA)====
+
===Anti-inflammatory therapy===
Numerous clinical trials and studies have evaluated
  −
EFAs particularly the n-3 EFA eicosapentenoic acid
  −
(EPA) and the n-6 EFA gamma-linolenic acid (GLA).
  −
Supplementation can result in altered plasma levels
  −
and incorporation into cell membranes, which may
  −
lead to production of less inflammatory leucotrienes
  −
and prostaglandins and improved cutaneous lipid
  −
barrier. Recent studies, however, have not found
  −
consistent changes in plasma, subcutaneous fat or
  −
cutaneous EFAs following supplementation in atopic
  −
and healthy dogs, and no correlation with the
  −
clinical response (1-3).
  −
Clinical results have been variable in controlled
  −
trials, and no relationship between efficacy and
  −
ratio of n-3/n-6 EFAs have been proven, although
  −
high doses seem to be more effective. Recent
  −
studies have shown that high quality, EFA enriched
  −
diets are beneficial in canine AD although how
  −
much of this is due to anti-inflammatory activity
  −
or cutaneous barrier improvements is unclear (4).
     −
===Allergen specific therapy===
+
In most cases, anti-inflammatory drugs are required in addition to topical treatments and allergen-specific therapy to control residual pruritus and inflammation. The dose and treatment regime should be adapted according to how successful other treatments are, the response to treatment and the presence of allergen in the environment (for example, pollen is present in the summer but not the winter). The aim should be to use the minimum dose that gives effective control of pruritus.
Allergen specific therapy will only be appropriate
  −
in animals with identified sensitivities. The aim of
  −
allergen testing is to identify allergens for avoidance
  −
and immunotherapy, not to confirm the diagnosis.
     −
====Allergen avoidance====
+
'''Glucocorticoids''' the most commonly used anti-inflammatory drugs in veterinary dermatology. Although they are cheap and efficacious, they are associated with many undesirable side effects. They should therefore be used with caution in atopic dermatitis. Drugs such as prednisolone or methyl-prednisolone can be used in the initial stages of treatment to break the itch-scratch cycle while animals begin to respond to other forms of control. They may also be used to manage seasonal atopy for a few months of the year. Short courses that gradually taper off can be implemented in flare-ups, or corticosteroids can be used as a very last resort in pets non-responsive to other forms of treatment. Topical steroids may be used where inflammation is localised to small areas of relatively hairless skin, or to control pyotraumatic dermatitis. In most cases, lesions are more widespread and so systemic administration is necessary. A dose should be established that induces remission, and this should be gradually tapered to the minimal effective dose, for example alternate day treatment. "Depot" injections of corticosteroids do not permit this flexibility in dosing, and should not be used. Glucocorticoids will suppress reactions to intradermal allergen tests and allergen-specific serology. However, the drugs are not thought to hamper the efficacy of vaccines.
Allergen avoidance measures can result in a significant
  −
reduction in exposure to house dust mite (5).
  −
Whether allergen avoidance results in clinically
  −
significant improvement is controversial, although
  −
one uncontrolled study demonstrated that allergen
  −
avoidance was beneficial in canine AD (6).  
     −
====Allergen specific immunotherapy (ASIT)====
+
'''Cyclosporine''' is an immunosuppressive drug that acts by suppressing T-cells, as well as mast cells and eosinophils. The doses used in atopy are immuno-modulating, and suppression of these cells impairs antigen presentation, IgE production and the development of inflammatory lesions<sup>3</sup>. Studies have suggested that cyclosporine is at least as effective as prednisolone for controlling atopic dermatitis<sup>3</sup>, but is better tolerated than the corticosteroid. The most likely side effects are transient anorexia and vomiting, but this can be avoided by administering cyclosporine with food. Uncommonly, hirsutism, alopecia, gingival hyperplasia, diarrhoea, tremors or erythema of the ears may be seen, but these effects are dose-dependent and reversible<sup>3</sup>. Immunosuppression is a potential concern, and so patients should be observed closely for opportunistic infections or infestations. Cyclosporine may also affect the efficacy of vaccination, and so some vets choose to treat with corticosteroids around this time instead. The drug minimally affects intradermal and serological allergy testing<sup>4</sup>.
ASIT involves the administration of gradually
  −
increasing amounts of allergen by subcutaneous
  −
injection. The mechanism of action is unknown
  −
but it is thought that administering large doses
  −
of allergen in an unusual route (i.e. subcutaneous
  −
instead of epidermal) induces tolerance. Many
  −
studies (albeit mostly open or retrospective)
  −
have shown that 60-80% of dogs have a greater
  −
than 50% improvement following ASIT. The
  −
best results seem to occur with early treatment,
  −
although a 9-12 month trial is necessary to assess
  −
the response in each case. Animals on ASIT
  −
require careful supervision to control microbial
  −
infections and other flare factors, to administer
  −
anti-inflammatory treatment as required and to
  −
adjust the dose and/or frequency according
  −
to the clinical response (Figure 1).
  −
The exact protocol varies widely but usually
  −
involves repeated injections a few days to 1-2
  −
weeks apart. Once the full dose is reached, the
  −
interval between injections can be extended.
  −
A rush protocol, where the initial loading course
  −
is given within a single day, was recently shown
  −
to be as effective as conventional ASIT in a small
  −
number of dogs (7). Recent reports also described
  −
starting with a full dose (monodose therapy).
  −
No adverse effects were seen in either case
  −
although the dogs were pre-medicated with
  −
an anti-histamine.
  −
Alum precipitated vaccines have a depot effect
  −
and require less frequent administration. Alum
  −
adjuvants potentiate IgE responses in experimental
  −
animals but no differences in efficacy between
  −
alum-precipitated and aqueous vaccines have been
  −
demonstrated in dogs. There are anecdotal reports
  −
of improved efficacy with low dose ASIT, but a
  −
controlled study, however, found no difference in
  −
efficacy between low dose and conventional
  −
alum-precipitated ASIT (8).
  −
If ASIT proves successful, the interval between
  −
injections can be extended. Increased pruritus
  −
before the next injection is due indicates that the
  −
interval is too long. The interval may also vary
  −
through the year, especially in pollen sensitive
  −
animals. Some dogs can be weaned off treatment,
  −
but most require maintenance injections every
  −
1-2 months.
  −
Re-testing may reveal new sensitivities in dogs
  −
with initially negative tests, dogs <12 months
  −
old at the time of the original test, if there has
  −
been a poor response to ASIT or where a good
  −
response is not maintained. Re-formulating ASIT
  −
can be beneficial in these dogs.
  −
Adverse effects are uncommon. Injection site
  −
reactions and anaphylactic shock are very rare,
  −
although many dermatologists advise giving the
  −
first 5-6 doses in a veterinary clinic. Increased
  −
pruritus after an injection indicates that the dose is
  −
too high although mild reactions can sometimes be
  −
managed with antihistamines.
     −
===Anti-inflammatory therapy===
+
Phytopica is a product containing a selection of Chinese herbs, which has been shown to be an efficacious, safe and palatable treatment for atopic dermatitis in dogs<sup>3</sup>. However, only a 20-50% improvement in signs is achieved, and so Phytopica is best used in combination with other control strategies and anti-inflammatory drugs.
Anti-inflammatory therapy is used as required
  −
to control residual pruritus and inflammation.
  −
Almost all atopics will require treatment in the
  −
short to medium term, but the dose, frequency
  −
and/or potency of drugs can be reduced if other
  −
treatments are successful in the long term.
     −
====Cyclosporine====
+
Hydrocortisone aceponate is a topical glucocorticoid that relieves pruritus. The topical administration and the fact that hydrocotisone aceponate is metabolised in the dermis means that many of the traditional side-effects of glucocorticoid therapy are avoided<sup>1, 3, 4</sup>. The product is potent, and rapidly exerts its effects following application. The formulation of the product makes it easy to apply, even to haired skin, and most animals only require every-other-day treatment. Adverse effects are rare, and only one dog has been reported to suffer a contact reaction.
Cyclosporine suppresses T-cells, which have been
  −
implicated in the pathogenesis of canine AD.
  −
I t also inhibits other key cells in allergic inflammatory reactions such as mast cells and
  −
eosinophils. This has profound effects on antigen
  −
presentation, IgE production, mononuclear cell
  −
activity and the development of inflammatory
  −
lesions, although at the doses used in canine AD,
  −
cyclosporine is immuno-modulating rather than
  −
immunosuppressive (Figure 2).
  −
Cyclosporine is rapidly absorbed and distributed.
  −
Bioavailability varies from 15-60% in individual
  −
dogs and is not affected by food. There is little
  −
correlation between trough levels and efficacy, and
  −
dose adjustments are made according to the clinical
  −
response rather than monitoring plasma levels.
  −
Metabolism is via the cytochrome P450 system.
  −
Numerous drugs can decrease metabolism, notably
  −
itraconazole and ketoconazole, which increases
  −
plasma concentrations, efficacy and the likelihood of
  −
adverse effects (Figure 3). Phenobarbital increases
  −
metabolism and decreases plasma levels.
  −
Cyclosporine is administered for canine AD at a
  −
dose of 5 mg/kg once daily. Controlled studies
  −
have shown that it is at least as effective as
  −
prednisolone and methyl-prednisolone (9,10),
  −
although this may take 2-3 weeks to become
  −
apparent. Glucocorticoids can be initially coadministered
  −
to achieve more rapid remission.
  −
Approximately one third of treated dogs require
  −
daily dosing, one third every other day and one
  −
third twice weekly to maintain remission.
  −
Using cyclosporine as part of an integrated
  −
management program can be more cost-effective
  −
than relying on it alone.
  −
The effect on intradermal testing and serology is
  −
thought to be minimal, although the data is sparse.
  −
Anecdotal data suggests that cyclosporine does
  −
not affect the response to ASIT any more than
  −
glucocorticoids although controlled studies have
  −
not yet been performed.
  −
Cyclosporine is well tolerated by the majority of dogs.
  −
Transient anorexia and vomiting are the most likely
  −
problems. Persistent vomiting is uncommon but
  −
may be eased by administering with food, and/or by
  −
using the gastrointestinal protectant sucralfate
  −
or H-2 blocking agents such as ranitidine. Other
  −
uncommon adverse effects include hirsuitism,
  −
increased shedding of hair and transient alopecia,
  −
gingival hyperplasia, papillomatosis, diarrhea,
  −
lameness and muscle tremors, and erythema
  −
and edema of the ears. These are largely dosedependent
  −
and reversible. The nephropathy,
  −
hepatopathy and hypertension seen in humans
  −
have not been recognized in dogs except at doses
  −
>20 mg/kg. Immunosuppression is a potential concern.
  −
Inhibition of cell-mediated immunity in particular
  −
could result in bacterial and protozoal infections,
  −
dermatophytosis and demodicosis. In practice,
  −
however, the risk appears to be very small and most
  −
atopic dogs experience fewer secondary infections
  −
following treatment. Feline and human patients on
  −
long term treatment have a small risk of developing
  −
lymphoma and cutaneous neoplasms. Lymphoplasmatoid
  −
dermatitis has been seen following
  −
doses >20 mg/kg and there is a single case report
  −
of lymphoma in an older dog following treatment
  −
for anal furunculosis. These have, however, not
  −
been reported in atopic dogs (11). Inhibition of
  −
T-helper cell function and β-cell activation could
  −
affect the response to vaccination. Some authors
  −
advocate withdrawing treatment for up to two
  −
weeks either side of vaccination, although this
  −
will lead to worsening of the skin condition. The
  −
pros and cons for each individual case should
  −
be discussed with the owner.
     −
====Phytopica™====
+
Antihistamines have some efficacy in the face of atopic dermatitis, and may have synergistic activity with essential fatty acids and glucocorticoids<sup>3, 4</sup>.
Phytopica™, a compound derived from Rehmannia
  −
glutinosa, Paeonia lactiflora and Glycyrrhiza
  −
uralensis improved canine AD in a preliminary
  −
study (14). In a recent randomized, double-blind
  −
and placebo-controlled trial of 120 dogs Phytopica™
  −
(200 mg/kg/day) appeared to be an efficacious,
  −
safe and palatable non-steroidal treatment for
  −
canine AD, although the effect was modest with
  −
most dogs achieving a 20-50% improvement in
  −
clinical signs (15). Responses are typically evident
  −
within four weeks (Figure 4). Adverse effects are
  −
self-limiting gastro-intestinal disturbances such as
  −
diarrhea and vomiting. This is generally a better
  −
safety profile than has been reported for other
  −
anti-inflammatory therapies (16).
     −
====Glucocorticoids====
+
==Prognosis==
Corticosteroids, synthesized in the adrenal cortex,
+
If left untreated, the degree of pruritus worsens, but atopic dermatitis is not life threatening unless intractable pruritus warrants euthanasia<sup>1</sup>. Some cases may spontaneously resolve.
have glucocorticoid (anti-inflammatory and
  −
gluconeogenic) and mineralocorticoid (salt
  −
and water balance) activity. Glucocorticoids are
  −
simultaneously the most used and abused drugs in veterinary dermatology. They are cheap, easy
  −
to administer and highly efficacious but are
  −
associated with a plethora of side-effects (17,18).
  −
At pharmacological doses they inhibit the expression
  −
of genes encoding a variety of molecules
  −
involved in immunity and inflammation, resulting
  −
in rapid and profound immunosuppression and
  −
decreased inflammation.
  −
Most quoted doses are for prednisolone (Table 1);
  −
the dose for other steroids is calculated according
  −
to the relative potency. Steroids also vary in
  −
their mineralocorticoid activity and duration of
  −
activity, but that suppression of the hypothalamicpituitary-
  −
adrenal (HPA) axis may last longer
  −
than the therapeutic effect. Only prednisolone
  −
and methyl-prednisolone are suitable for long term
  −
alternate day dosing as their duration of activity
  −
should leave at least 12 hours for the HPA axis
  −
to recover. The formulation also has an impact:
  −
soluble esters (such as succinates and phosphates)
  −
have a rapid onset and shorter duration of
  −
action; acetates have a moderate onset and
  −
duration; and acetonides and dipropionates are
  −
long-acting depot preparations.
  −
Glucocorticoids are highly effective in canine
  −
AD, but must be used with care and, ideally,
  −
as a last resort. Exploring alternative approaches
  −
will help minimize the dose and frequency
  −
required. Genuine seasonal AD that requires
  −
3-4 months treatment each year, however, can
  −
usually be managed successfully with minimal
  −
problems. Short courses (0.5-1.0 mg/kg once
  −
daily for 3-5 days) can also be administered to
  −
treat flares of inflammation in dogs otherwise
  −
well controlled on other medication.
  −
Topical treatment directs the steroid to affected skin
  −
and avoids the need for systemic therapy. Topical
  −
glucocorticoids can be used where inflammation is
  −
localized to relatively hairless skin, pyotraumatic
  −
dermatitis (‘hot-spots’) or in the ears and eyes.
  −
More potent products containing betamethasone
  −
etc. can be used once or twice daily initially, but
  −
hydrocortisone is better for long term, alternate day
  −
treatment. Fuciderm® (contains betamethasone) is
  −
a good choice as the gel formulation allows rapid
  −
penetration and drying.
  −
Systemic therapy is necessary with more severe
  −
or widespread lesions. 0.5-1.0 mg/kg prednisolone
  −
is given once daily until remission. You can then
  −
administer the same dose every other day and then
  −
reduce the dose by 50% every 7-14 days until the
  −
lowest maintenance dose is established; or,
  −
gradually wean the alternate day dose off, and
  −
then establish the lowest every other day
  −
maintenance dose. The only suitable systemic
  −
drugs for alternate day dosing are prednisolone
  −
or methyl-prednisolone, but triamcinolone,
  −
betamethasone or dexamethasone can be used
  −
to achieve remission in severe cases. Injectable
  −
preparations should not be used unless absolutely
  −
necessary, as it cannot be withdrawn, the dose
  −
cannot be altered, nor the hypothalamic-pituitaryadrenal
  −
(HPA) axis allowed to recover.
  −
Glucocorticoids will suppress reactions to intradermal
  −
allergen tests, although the effect on serology is believed to be less marked. It is currently
  −
recommended that you withdraw topical glucocorticoids
  −
for at least two weeks, short acting oral
  −
glucocorticoids for at least three weeks and longer
  −
acting injectable glucocorticoids for at least six
  −
weeks before allergy testing. Dogs on long term
  −
treatment or with iatrogenic hyperadrenocorticism
  −
may need considerably longer withdrawal
  −
times (Figure 5). Glucocorticoids are frequently
  −
administered to control inflammation during the
  −
induction phase of immunotherapy. This does not
  −
appear to affect the response rate although there
  −
are no controlled studies.
  −
Adverse effects arise from the glucocorticoid
  −
and mineralocorticoid activity as well as
  −
suppression of the HPA axis and endogenous
  −
steroid production. Common acute side-effects
  −
include polyuria and polydipsia. The risk of
  −
these problems developing can be reduced by
  −
using methyl-prednisolone, which has much less
  −
mineralocorticoid activity. Other acute sideeffects
  −
include polyphagia and weight gain
  −
(which can be managed using a low calorie diet),
  −
panting and behavioral changes (including
  −
dullness and, rarely, aggression). The onset of
  −
iatrogenic hyperadrenocorticism is dose and
  −
duration dependent, but there is a wide
  −
variation in tolerance between individuals.
  −
Immunosuppression and secondary infections
  −
are quite common with long term treatment.
  −
Inhibition of cell-mediated immunity can result
  −
in demodicosis, dermatophytosis and infections
  −
with intracellular organisms. Immunosuppression
  −
and alterations in cutaneous barrier function
  −
commonly result in superficial pyoderma.
  −
Production of dilute urine is a factor that
  −
contributes to cystitis.
  −
Some of these infections may be clinically
  −
inapparent, as steroid therapy may mask some of
  −
the associated inflammation and characteristic
  −
clinical signs such as pruritus or dysuria.
  −
Because humoral immunity is less affected,
  −
animals can develop adequate antibody titers
  −
following vaccination. For this reason, short
  −
term treatment may be used to control the
  −
clinical signs if cyclosporine has to be withdrawn
  −
because of routine vaccination.
  −
 
  −
====Hydrocortisone aceponate====
  −
Hydrocortisone aceponate is a novel topical
  −
diester glucocorticoid for the treatment of pruritus
  −
in dogs. Topical diester glucocorticoids overcome
  −
many of the adverse effects traditionally
  −
associated with systemic or topical glucocorticoid
  −
therapy. They are rapidly absorbed and exert
  −
potent anti-inflammatory effects within the
  −
epidermis and superficial dermis. Metabolism
  −
within the dermis, however, ensures that very
  −
little active compound reaches deeper tissues
  −
and the circulation, minimizing skin thinning
  −
and systemic effects. The topical formulation,
  −
furthermore, eases topical administration. The
  −
small dose volume, very small droplet size and
  −
volatile carrier help to ensure quick and easy
  −
application, penetration of even haired skin and
  −
rapid drying with minimal cutaneous after
  −
effects. The spray is formulated such that two
  −
sprays from 10 cm away will penetrate the coat
  −
and treat a 10 x 10 cm (i.e. palm sized area of
  −
skin). Early studies (unpublished) demonstrated good
  −
efficacy and safety in short term treatment of
  −
various pruritic disorders in dogs including
  −
pyotraumatic dermatitis and f lea allergic
  −
dermatitis. An open-label pilot study and
  −
preliminary findings from a randomized, doubleblind,
  −
placebo controlled study found that
  −
Cortavance® was effective and well-tolerated in
  −
managing canine AD. One dog has suffered a
  −
contact reaction, but adverse effects have not
  −
otherwise been noted. Once daily administration
  −
was sufficient to induce remission, after which a
  −
proportion of dogs can be maintained on every
  −
other day therapy. Twice weekly administration,
  −
however, resulted in a relapse in most dogs.
     −
====Antihistamines====
+
{{Learning
A large review of clinical trials (16) concluded
+
|Vetstream = [https://www.vetstream.com/canis/Content/Disease/dis00214.asp Atopy]<br>[https://www.vetstream.com/canis/Content/Illustration/ill02158.asp Atopy: acute on chronic]<br>[https://www.vetstream.com/canis/Content/Illustration/ill02166.asp ears]<br>[https://www.vetstream.com/canis/Content/Illustration/ill02164.asp Atopy: extremities]<br>[https://www.vetstream.com/canis/Content/Illustration/ill02165.asp Atopy: peri-orbital]
that there is no more than fair evidence of
+
|literature search = [http://www.cabdirect.org/search.html?q=title:(%22Atopic+Dermatitis%22) Atopic Dermatitis publications]
medium efficacy for the first generation antihistamines
  −
clemastine and a combination
  −
of chlorpheniramine and hydroxyzine, and
  −
the second generation (non-sedating) drug
  −
oxatomide. There may however be some synergistic
  −
activity with EFAs and glucocorticoids.
  −
Adverse effects of first generation drugs are
  −
uncommon and are usually linked to drowsiness.
  −
Adverse effects to second generation drugs
  −
are more common and include gastrointestinal
  −
tract upsets and cardiac arrhythmias.
     −
==Prognosis==
+
[http://www.cabdirect.org/search.html?q=title:(%22Atopic+Dermatitis%22)+AND+od:(dogs) Atopic Dermatitis in dogs publications]
   −
If left untreated, the degree of pruritus worsens, but atopic dermatitis is not life threatening unless intractable pruritus warrants euthanasia<sup>1</sup>. Some cases may spontaneously resolve.
+
[http://www.cabdirect.org/search.html?q=title:(%22Atopic+Dermatitis%22)+AND+od:(cats) Atopic Dermatitis in cats publications]
 +
}}
    
==Links==
 
==Links==
Line 440: Line 94:  
#Merck & Co (2008) '''The Merck Veterianry Manual (Eight Edition)''', ''Merial''.
 
#Merck & Co (2008) '''The Merck Veterianry Manual (Eight Edition)''', ''Merial''.
    +
 +
{{review}}
 +
 +
{{OpenPages}}
 
[[Category:Allergic Skin Diseases]]
 
[[Category:Allergic Skin Diseases]]
 
+
[[Category:Dermatological Diseases - Dog]][[Category:Immunological Diseases - Dog]] [[Category:Dermatological Diseases - Cat]][[Category:Immunological Diseases - Cat]]
[[Category:To Do - Blood]][[Category:To Do - Lizzie]]
+
[[Category:Expert Review]]
 +
[[Category:Type I Hypersensitivity Diseases]]
 +
[[Category:Integumentary System - Hypersensitivity Reactions]]
173

edits